DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
36	表皮水疱症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00936533 (ClinicalTrials.gov)	May 2009	8/7/2009	Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita	Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita - a Double-blind Placebo-controlled Phase II Proof of Concept Study	Epidermolysis Bullosa Simplex	Drug: Dysport® (Botulinumtoxin A (Btx A));Drug: Placebo	Uppsala University	NULL	Recruiting	16 Years	N/A	Both	40	Phase 2	Sweden

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00936533
(ClinicalTrials.gov)

May 2009

8/7/2009

Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita - a Double-blind Placebo-controlled Phase II Proof of Concept Study

Epidermolysis Bullosa Simplex

Drug: Dysport® (Botulinumtoxin A (Btx A));Drug: Placebo

Uppsala University

NULL

Recruiting

16 Years

N/A

Both

Phase 2

Sweden